Single User License
INR 170425
Site License
INR 340850
Corporate User License
INR 511275

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Hemorrhage Global Clinical Trials Review, H1

Hemorrhage Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Hemorrhage Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hemorrhage Global Clinical Trials Review, H1, 2015" provides an overview of Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Hemorrhage 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Hemorrhage to Hematological Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Hemorrhage to Hematological Disorders Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Hemorrhage 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Hemorrhage Therapeutics Clinical Trials 31

Prominent Drugs 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Gynuity Health Projects 33

Clinical Trial Overview of Gynuity Health Projects 33

Johnson & Johnson 35

Clinical Trial Overview of Johnson & Johnson 35

Pfizer Inc. 36

Clinical Trial Overview of Pfizer Inc. 36

CSL Limited 37

Clinical Trial Overview of CSL Limited 37

Takeda Pharmaceutical Company Limited 38

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 38

Merck & Co., Inc. 39

Clinical Trial Overview of Merck & Co., Inc. 39

Bayer AG 40

Clinical Trial Overview of Bayer AG 40

RTI International 41

Clinical Trial Overview of RTI International 41

Ferring International Center S.A. 42

Clinical Trial Overview of Ferring International Center S.A. 42

C. H. Boehringer Sohn AG & Co. KG 43

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43

Clinical Trial Overview of Top Institutes / Government 44

Tehran University of Medical Sciences 44

Clinical Trial Overview of Tehran University of Medical Sciences 44

Ain Shams University 45

Clinical Trial Overview of Ain Shams University 45

Cairo University 46

Clinical Trial Overview of Cairo University 46

Rigshospitalet 47

Clinical Trial Overview of Rigshospitalet 47

The Lunenfeld-Tanenbaum Research Institute 48

Clinical Trial Overview of The Lunenfeld-Tanenbaum Research Institute 48

Chinese University of Hong Kong 49

Clinical Trial Overview of Chinese University of Hong Kong 49

Kashan University of Medical Sciences and Health Services 50

Clinical Trial Overview of Kashan University of Medical Sciences and Health Services 50

Qazvin University Of Medical Sciences 51

Clinical Trial Overview of Qazvin University Of Medical Sciences 51

Aga Khan University 52

Clinical Trial Overview of Aga Khan University 52

Asan Medical Center 53

Clinical Trial Overview of Asan Medical Center 53

Five Key Clinical Profiles 54

Appendix 75

Abbreviations 75

Definitions 75

Research Methodology 76

Secondary Research 76

About GlobalData 77

Contact Us 77

Disclaimer 77

Source 78

List of Figures

Hemorrhage Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Hemorrhage to Hematological Disorders Clinical Trials, G7 Countries (%), 2015* 15

Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Hemorrhage to Hematological Disorders Clinical Trials, E7 Countries (%), 2015* 18

Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Hemorrhage Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 76

List of Tables

Hemorrhage Therapeutics, Global, Clinical Trials by Region, 2015* 7

Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Hemorrhage to Hematological Disorders Clinical Trials, G7 Countries (%), 2015* 15

Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Hemorrhage to Hematological Disorders Clinical Trials, E7 Countries (%), 2015* 18

Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Hemorrhage Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Hemorrhage Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Hemorrhage Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Hemorrhage Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynuity Health Projects, 2015* 33

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 35

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 36

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2015* 37

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 38

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 39

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 40

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by RTI International, 2015* 41

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 42

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 43

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 44

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Ain Shams University, 2015* 45

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Cairo University, 2015* 46

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2015* 47

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The Lunenfeld-Tanenbaum Research Institute, 2015* 48

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 49

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Kashan University of Medical Sciences and Health Services, 2015* 50

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Qazvin University Of Medical Sciences, 2015* 51

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2015* 52

Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Gynuity Health Projects

Johnson & Johnson

Pfizer Inc.

CSL Limited

Takeda Pharmaceutical Company Limited

Merck & Co., Inc.

Bayer AG

RTI International

Ferring International Center S.A.

C. H. Boehringer Sohn AG & Co. KG

Hemorrhage Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Hemorrhage, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com